Guidance on the use of imatinib for chronic myeloid leukaemia

Technology appraisal guidance
Reference number: TA70
Published: 22 October 2003
Last updated: 21 January 2016

TA70 Leukaemia (chronic myeloid) - imatinib: appendix b - proposal paper presented to the Institute's Guidance Executive

TA70 Leukaemia (chronic myeloid) - imatinib: appendix b - proposal paper presented to the Institute's Guidance Executive

TA70 Leukaemia (chronic myeloid) - imatinib: appendix b - proposal paper presented to the Institute's Guidance Executive
26 August 2014
(570.54 Kb 46 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 26 August 2014